Skip to content

Public FDA record

Z-3123-2024: FILMARRAY TORCH MODULE BOX, HTFA-ASY-0003, HTFA-ASY-0003-W, HTFA-ASY-0003U

Recall record Z-3123-2024 for BioFire Diagnostics, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-3123-2024
Company in FDA record
BioFire Diagnostics, LLC
FDA classification date
Sep 11, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Some automated in vitro diagnostic modules and instruments manufactured or serviced between May 2022 and May 2024 were calibrated with internal equipment that may lead modules and instruments to report higher melting temperatures, which may lead to erroneous results including false positive Salmonella, Giardia lamblia, false positive/negative Norovirus, and false negative MRSA.

Source facts

Action
On 8/7/24 Biomerieux sent recall notices to customers who were asked to do the following: 1) Utilize http://biofiredx.com/fsca5788-1/ to determine which of your instruments are impacted. 2) If your instrument is on the impacted list, it needs to be returned to the firm's Service Center for recalibration; your local contact will reach out to you to coordinate instrument return. 3) Continue to use all your instruments in accordance with product labeling (instructions for use) while waiting for service. 4) For BIOFIRE GI Panel Users, you may continue using the product as directed in the package insert, but if a positive Salmonella or Giardia lamblia result is inconsistent with clinical presentation, consider confirming the positive using another method or rerun the sample on an unaffected instrument. In patients suspected of Norovirus infection, please consider confirming Norovirus results via another method prior to reporting those results or rerun the sample on an unaffected instrument. 5) For BCID2 users, you may continue using the product as directed in the package insert; however, in patients with a Staphylococcus aureus detected result on the BCID2 panel AND suspected of a MRSA infection, please confirm all negative MRSA results via another method prior to reporting or rerun the sample on an unaffected instrument. 6) For RP2.1, RP2.1plus, ME, PN, PNplus and JI users, you may continue using the product as directed in the package insert; No confirmation of results are required. 7) If you have further distributed impacted instrument(s), identify any recipients and notify them at once by sending them a copy of the recall notice and acknowledgement form. 8) Complete all fields of the accompanying Acknowledgment of Receipt Form via email and return to USfieldactions@biomerieux.com or the form can be filled out electronically by following URL: https://www.biofiredx.com/recall5788-1/ Customers with questions can contact Technical Support at biofiresupport@biomer
Initiated
2024-08-07
Root cause
Under Investigation by firm
Distribution
Worldwide - US Nationwide distribution including in the states of NC, TX, OH, CA, KS, AL, WA, NY, PA, IL, WI, KY, LA, NE, FL, UT, IA, SC, VA, AZ, CO, WV, MO, TN, MN, DC, DE, OK, WY, IN, NJ, NM, ID, OR, MS, SD, MI, MT, GA, HI, NV, MD, MA, AR, NH, PR, ND, VT, CT, AK, ME, RI and the countries of Korea, Canada, Singapore distributors, Canada, Canada, China, China, Singapore, Canada, China, Mexico, Japan, Chile, Chile, Singapore, Mexico, Hong King, China, Chile, Singapore, Philippines, Korea, Chile, Korea, Australia, Greece.
Recall number
Z-3123-2024
Recall status
Open, Classified
CDRH record ID
209138
FDA classified
2024-09-11
Recall event number
95019

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗